Close Menu

MRSA

Cepheid last week reported a 28 percent spike in first-quarter revenues driven primarily by strong sales in its clinical diagnostics business, including record sequential growth in clinical reagent sales.

Roche last week said that it has received US Food and Drug Administration approval of a new pre-analytical instrument that integrates primary tube handling into its Cobas molecular testing platform.

By Ben Butkus
Abbott and Dallas-based Genetics Laboratory are co-developing a molecular test designed to rapidly detect microorganisms that cause orthopedic infections, Abbott said this week.

By Ben Butkus
Molecular Detection said this week that it has completed a $1.5 million financing to advance commercialization of its Detect-Ready molecular diagnostic panels for detecting sepsis and gastrointestinal diseases.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Molecular diagnostic firm Molecular Detection today said that it has completed a $1.5 million financing round to advance its tests for detecting sepsis and gastrointestinal diseases.

Lucigen today announced a $2.5 million grant from the National Institutes of Health to develop metagenomic DNA libraries for the identification of new antimicrobial and other anti-infective drug candidates.

Pages

Three genetic testing companies form a coalition to influence how Congress considers genetic privacy, The Hill reports.

University of California, San Diego researchers investigate how skin care products influence the skin microbiome, Scientific American reports.

The Wall Street Journal examines billing codes used by uBiome.

In PNAS this week: links between lung adenocarcinoma and lncRNA, algorithm to impute and cluster Hi-C interaction profiles from single cells, and more.